Title : A randomized, placebo-controlled trial of the benzoquinone idebenone in a mouse model of OPA1-related dominant optic atrophy reveals a limited therapeutic effect on retinal ganglion cell dendropathy and visual function.

Pub. Date : 2016 Apr 5

PMID : 26820596






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A randomized, placebo-controlled trial of the benzoquinone idebenone in a mouse model of OPA1-related dominant optic atrophy reveals a limited therapeutic effect on retinal ganglion cell dendropathy and visual function. idebenone OPA1, mitochondrial dynamin like GTPase Mus musculus
2 We report a randomized, placebo-controlled trial of idebenone at 2000 mg/kg/day in 56 Opa1 mutant mice (B6;C3-Opa1(Q285STOP)), with RGC dendropathy and visual loss, and 63 wildtype mice. idebenone OPA1, mitochondrial dynamin like GTPase Mus musculus
3 ATP levels were raised by 0.57 nmol/mg (97.73%, p=0.035) in brain from idebenone-treated Opa1 mutant mice, but in the liver there was an 80.35% (p=0.011) increase in oxidative damage. idebenone OPA1, mitochondrial dynamin like GTPase Mus musculus